Terms: = Lung cancer AND CD79A, ENSG00000105369, 973, P11912, MB-1, IGA AND Prognosis
56 results:
1. Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma.
Wu X; Zhao X; Zhou C; Wei N; Xu Z; Zhang X
J Cancer Res Clin Oncol; 2024 Apr; 150(4):188. PubMed ID: 38602568
[TBL] [Abstract] [Full Text] [Related]
2. The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer.
Xu W; Liu X; Yan C; Abdurahmane G; Lazibiek J; Zhang Y; Cao M
Sci Rep; 2024 Mar; 14(1):7568. PubMed ID: 38555313
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a new risk score model based on hypoxia and EMT-related genes for predicting lung squamous cell carcinoma prognosis.
Zhuang X; Yu S; Yang S; Chen J; Feng J
Medicine (Baltimore); 2023 Nov; 102(44):e35572. PubMed ID: 37933024
[TBL] [Abstract] [Full Text] [Related]
4. Polymeric immunoglobulin receptor (pIgR) in cancer.
Chae J; Choi J; Chung J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17683-17690. PubMed ID: 37897659
[TBL] [Abstract] [Full Text] [Related]
5. Opportunities for Savings in Risk Arrangements for Oncologic Care.
Landon BE; Lam MB; Landrum MB; McWilliams JM; Meneades L; Wright AA; Keating NL
JAMA Health Forum; 2023 Sep; 4(9):e233124. PubMed ID: 37713209
[TBL] [Abstract] [Full Text] [Related]
6. Comprehensive analysis of the lncRNAs-related immune gene signatures and their correlation with immunotherapy in lung adenocarcinoma.
Yang Z; Zhu J; Yang T; Tang W; Zheng X; Ji S; Ren Z; Lu F
Br J Cancer; 2023 Oct; 129(9):1397-1408. PubMed ID: 37543671
[TBL] [Abstract] [Full Text] [Related]
7. Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing.
Wang H; Han G; Chen J
Aging (Albany NY); 2023 Jun; 15(12):5339-5354. PubMed ID: 37335089
[TBL] [Abstract] [Full Text] [Related]
8. p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Köbel M; Kang EY; Weir A; Rambau PF; Lee CH; Nelson GS; Ghatage P; Meagher NS; Riggan MJ; Alsop J; Anglesio MS; Beckmann MW; Bisinotto C; Boisen M; Boros J; Brand AH; Brooks-Wilson A; Carney ME; Coulson P; Courtney-Brooks M; Cushing-Haugen KL; Cybulski C; Deen S; El-Bahrawy MA; Elishaev E; Erber R; Fereday S; ; Fischer A; Gayther SA; Barquin-Garcia A; Gentry-Maharaj A; Gilks CB; Gronwald H; Grube M; Harnett PR; Harris HR; Hartkopf AD; Hartmann A; Hein A; Hendley J; Hernandez BY; Huang Y; Jakubowska A; Jimenez-Linan M; Jones ME; Kennedy CJ; Kluz T; Koziak JM; Lesnock J; Lester J; Lubiński J; Longacre TA; Lycke M; Mateoiu C; McCauley BM; McGuire V; Ney B; Olawaiye A; Orsulic S; Osorio A; Paz-Ares L; Ramón Y Cajal T; Rothstein JH; Ruebner M; Schoemaker MJ; Shah M; Sharma R; Sherman ME; Shvetsov YB; Singh N; Steed H; Storr SJ; Talhouk A; Traficante N; Wang C; Whittemore AS; Widschwendter M; Wilkens LR; Winham SJ; Benitez J; Berchuck A; Bowtell DD; Candido Dos Reis FJ; Campbell I; Cook LS; DeFazio A; Doherty JA; Fasching PA; Fortner RT; García MJ; Goodman MT; Goode EL; Gronwald J; Huntsman DG; Karlan BY; Kelemen LE; Kommoss S; Le ND; Martin SG; Menon U; Modugno F; Pharoah PD; Schildkraut JM; Sieh W; Staebler A; Sundfeldt K; Swerdlow AJ; Ramus SJ; Brenton JD
J Pathol Clin Res; 2023 May; 9(3):208-222. PubMed ID: 36948887
[TBL] [Abstract] [Full Text] [Related]
9. Enhanced immune complex formation in the lungs of patients with dermatomyositis.
Zaizen Y; Okamoto M; Azuma K; Fukuoka J; Hozumi H; Sakamoto N; Suda T; Mukae H; Hoshino T
Respir Res; 2023 Mar; 24(1):86. PubMed ID: 36934274
[TBL] [Abstract] [Full Text] [Related]
10. The Impact of Sarcopenia Onset Prior to cancer Diagnosis on cancer Survival: A National Population-Based Cohort Study Using Propensity Score Matching.
Su CH; Chen WM; Chen MC; Shia BC; Wu SY
Nutrients; 2023 Mar; 15(5):. PubMed ID: 36904245
[TBL] [Abstract] [Full Text] [Related]
11. Development and validation of an immune-related gene signature for prognosis in lung adenocarcinoma.
Guo Z; Qi X; Li Z; Yang J; Sun Z; Li P; Chen M; Cao Y
IET Syst Biol; 2023 Feb; 17(1):27-38. PubMed ID: 36728032
[TBL] [Abstract] [Full Text] [Related]
12. T cell-related prognostic risk model and tumor immune environment modulation in lung adenocarcinoma based on single-cell and bulk RNA sequencing.
Zhang J; Liu X; Huang Z; Wu C; Zhang F; Han A; Stalin A; Lu S; Guo S; Huang J; Liu P; Shi R; Zhai Y; Chen M; Zhou W; Bai M; Wu J
Comput Biol Med; 2023 Jan; 152():106460. PubMed ID: 36565482
[TBL] [Abstract] [Full Text] [Related]
13. Identification of immune-associated prognostic biomarkers in lung adenocarcinoma on the basis of gene co-expression network.
Zhang J; Chen A; Xue Z; Liang C
Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):334-346. PubMed ID: 36351297
[No Abstract] [Full Text] [Related]
14. Identify miRNA-mRNA regulation pairs to explore potential pathogenesis of lung adenocarcinoma.
Fan X; Zou X; Liu C; Peng S; Zhang S; Zhou X; Zhu J; Zhu W
Aging (Albany NY); 2022 Oct; 14(20):8357-8373. PubMed ID: 36260870
[TBL] [Abstract] [Full Text] [Related]
15. Development of exploratory algorithms to aid in risk of malignancy prediction of indeterminate pulmonary nodules.
Jeanblanc N; Jackson L; Gawel S; Brophy S; Vaidya S; Syed S; Davis GJ; Borgia JA
Clin Chim Acta; 2022 Oct; 535():197-202. PubMed ID: 36087784
[TBL] [Abstract] [Full Text] [Related]
16. Diagnostic Accuracy of F18-fluorodeoxyglucose Positron Emission Tomography- computed Tomography for the Detection of Non-small Cell lung cancer Recurrence: A Systematic Review and Meta-analysis.
Chen Y; Zhang D; Fan K
Curr Med Imaging; 2022; 19(5):476-485. PubMed ID: 35927894
[TBL] [Abstract] [Full Text] [Related]
17. A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in lung Adenocarcinoma.
Qian L; Wang F; Lu SM; Miao HJ; He X; Feng J; Huang H; Shi RF; Zhang JG
J Immunol Res; 2022; 2022():1951620. PubMed ID: 35509981
[TBL] [Abstract] [Full Text] [Related]
18. Predicting mortality after hospitalisation for COPD using electronic health records.
Pellicori P; McConnachie A; Carlin C; Wales A; Cleland JGF
Pharmacol Res; 2022 May; 179():106199. PubMed ID: 35381341
[TBL] [Abstract] [Full Text] [Related]
19. Identification of SSBP1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
Huang J; Xie ZF
Math Biosci Eng; 2022 Jan; 19(3):3022-3035. PubMed ID: 35240818
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic impact of count of extratumoral lymphatic permeation in lung adenocarcinoma and its relation to the immune microenvironment.
Niimi T; Nakai T; Aokage K; Tane K; Miyoshi T; Samejima J; Miyazaki S; Taki T; Sakamoto N; Sakashita S; Watanabe R; Kojima M; Suzuki K; Tsuboi M; Ishii G
Cancer Sci; 2022 Apr; 113(4):1497-1506. PubMed ID: 35181964
[TBL] [Abstract] [Full Text] [Related]
[Next]
